Sun Yat-sen University

This study tested a combination of two drugs—toripalimab (an immunotherapy) and chidamide (a targeted therapy)—in women with advanced cervical cancer that had spread, returned, or could not be removed by surgery. The goal was to see if the combination was safe and could shrink tu…

This study looked at whether the drug toripalimab, given after standard chemoradiation, could help people with limited-stage small cell lung cancer live longer without their cancer getting worse. The trial enrolled 170 adults aged 18-75 whose cancer had not grown after initial tr…